Drug class in one race
KAT6A / KAT6B drugs for Non-Small Cell Lung Cancer
2 tracked KAT6A / KAT6B drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the KAT6A / KAT6B page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 Phase 1